Cefuroxime MIP

Medicinal product

(Invented) name

Cefuroxime MIP

Active substance (s)

Cefuroksimas

Strength

750 mg

Pharmaceutical form

milteliai injekciniam tirpalui

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01DC02, Cefuroxime

Marketing authorisation holder

MIP Pharma GmbH, Vokietija

Date of authorisation

2013-02-08

Date of renewal

2022-05-18

Documents

3197 Cefuroxime MIP PCS PL 2023 05 22.docx

3197 Pakuotės lapelis 2023 05 22.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NO/H/0218/001DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra:	1 vnt.
Cefuroksimas	750 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
46851	60661	1060661	flakonas	N1		Receptinis	LT/1/13/3197/001	Netiekiama	-	-	No	-	-
55161	69194	1069194	flakonas	N5		Receptinis	LT/1/13/3197/002	Netiekiama	-	-	No	-	-
55162	69195	1069195	flakonas	N10		Receptinis	LT/1/13/3197/003	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-05-18	Perregistruotas
2013-02-08	Registruotas